Arteriocyte Medical Systems
Date | Investors | Amount | Round |
---|---|---|---|
- | N/A | - | |
$10.0m | Early VC | ||
$100k | Early VC | ||
N/A | $150k | Debt | |
N/A | Acquisition | ||
Total Funding | $10.1m |
Related Content
Recent News about Arteriocyte Medical Systems
EditIsto Biologics is a company specializing in orthobiologics, focusing on improving patient quality of life through advanced biological solutions. The company operates in the healthcare sector, specifically targeting spine, orthopedics, and sports medicine. Isto Biologics serves a diverse clientele including physicians, hospital administrators, and distributors. Its business model revolves around developing and selling biologic products such as bone graft extenders and substitutes, which are used in surgical and clinical settings to enhance healing and bone fusion. The company generates revenue by selling these specialized products directly to healthcare providers and through partnerships with distributors. Isto Biologics leverages the science of human biology to create innovative solutions that are both cost-effective and clinically proven, ensuring better patient outcomes.
Keywords: orthobiologics, spine, orthopedics, sports medicine, bone graft, biologics, healthcare, patient-centric, regenerative, clinical efficacy.